9.30am - 10.00am Registration and morning coffee

10.00am - 10.05am

Welcome and Official Opening
Glenn Cross, Chief Executive Officer, AusBiotech

10.05am - 10.30am

KEYNOTE: Update on the current state of life science investing in Asia

Scarlett Chen, Director of Strategic Investments, Prudential - to be confirmed

10.30am - 11.15am

Company Spotlight Presentations

- Dr Brad Walsh, Chief Executive Officer, Minomic International

- Dr Rosalind Wilson, Chief Executive Officer, Factor Therapeutics (ASX:FFT)

- Dr Ross Macdonald, Managing Director and Chief Executive Officer, Cynata Therapeutics Limited (ASX:CYP)

- John Martin, Chief Executive Officer, Regeneus (ASX:RGS)

- Stephen Lydeamore, Chief Financial Officer, Bionomics Limited (ASX:BNO)

11.15am - 11.45am Morning tea and networking opportunity

11.45am - 12.15pm

KEYNOTE: Australian Life Science companies raising capital nd forming partnershipss in the Greater China Region

Mr Rani Jarkas, Chairman, Cedrus Investments, Hong Kong

12.15pm - 1.00pm

Company Spotlight Presentations

- Malcolm McColl, Managing Director and Chief Executive Officer, Viralytics Limited (ASX:VLA)

- David Nelson, Chief Executive Officer, CARP Pharmaceuticals - tbc

- Dr Ryan Parlett, Director Business Management Pharma Services, Patheon Biologics Australia

- Megan Ford, Senior Director Research & Development, IQVIA

- Professor Grant Morahan, Advanced Genetic Diagnostics – tbc

1.00pm - 2.00pm

Lunch and networking opportunity

2.00pm - 2.15pm

KEYNOTE: Pharma 2030 - opportunities for biotech companies, busiess models and trends

Jla Zhou
, Strategy Group, KPMG, Hong Kong

2.15pm - 3.00pm

Company Spotlight Presentations

-Companies to be confirmed

3.00pm - 3.15pm

KEYNOTE: title and speaker to be confirmed

3.15pm - 3.30pm Close of Conference
Glenn Cross,
Chief Executive Officer, AusBiotech

3.30pm - 5.00pm Networking Reception
Venue: KPMG Hong Kong